At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

Leeds Teaching Hospitals NHS Trust (LTHT) has announced that it is piloting a new artificial intelligence (AI) and machine learning software system for prostate cancer diagnosis. Working in ...

The conference will return to Vienna AirportCity on 23 to 24 October 2024 Samedan has announced that on 23 to 24 October 2024, its FlyPharma Conference will make a welcome return to Office Park 4, ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

A recent study published in the American Journal of Psychiatry suggests that menopausal hormone therapy (HRT) may reduce the risk of psychosis relapse in menopausal women. The research, led by Bodyl ...

Patients with relapsed multiple myeloma gain access to life-extending therapy The Scottish Medicines Consortium (SMC) has approved Tecvayli – also known as teclistamab – for patients with relapsed and ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO), has announced a partnership with CurifyLabs, a Finnish ...

World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition that claims millions of lives each year. Sepsis results from a dysregulated ...

Nxera Pharma and Cancer Research UK are set to present their ongoing Phase 1/2a clinical trial of the cancer immunotherapy drug HTL0039732 at the European Society for Medical Oncology (ESMO) Congress ...